Tags

baricitinib
Jan 1, 2023
Double-Blind Method
Jan 1, 2023
Female
Jan 1, 2023
Male
Jan 1, 2023
Middle Aged
Jan 1, 2023
RNA
Jan 1, 2023
safety
Jan 1, 2023
SARS-CoV-2
Jan 1, 2023
Vaccination
Jan 1, 2023
Viral
Jan 1, 2023